Comparing Modified Thoracoabdominal Nerve Block Perichondrial Approach M-TAPA to Intravenous Opioids for Pain Relief After Laparoscopic Gallbladder Surgery

What this Trial Is About

This research aims to evaluate the benefits of using a Peripheral Nerve Block called the Modified Thoracoabdominal Perichondrial Approach M-TAPA compared to standard intravenous opioids in patients undergoing laparoscopic cholecystectomy. The goal is to see if M-TAPA can reduce pain and the need for opioid medication after surgery. The study involves adult patients aged 18 to 65 years with specific health criteria. Participants will be randomly assigned to one of two groups. One group P1 receives the M-TAPA nerve block administered by an anesthesiologist using ultrasound guidance during surgery along with general anesthesia. The other group P2 receives only intravenous opioids after surgery without the nerve block. Both groups undergo the same laparoscopic cholecystectomy procedure. The nerve block involves injections on both sides of the upper abdomen with the local anesthetic bupivacaine. Patients are closely monitored for side effects during and after the procedure. During the study, participants will be assessed before surgery, during anesthesia, and up to 24 hours after surgery. Pain levels are measured using a Numeric Rating Scale at multiple time points, and opioid use is tracked via a PCA infusion device. Recovery quality is also evaluated with a questionnaire before surgery and 24 hours afterward. Vital signs and side effects are monitored continuously in the recovery room. The study focuses on measuring pain relief effectiveness and opioid consumption within the first 24 hours post-operation.

Effectiveness Of Modified-Thoracoabdominal Nerve Block Perichondrial Approach (M-TAPA) In Laparoscopic Cholecystectomy